Drug · DIN 02545969
AZITHROMYCIN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 26, 2025; first marketed February 26, 2025.
- Drug Identification Number (DIN)
- 02545969
- Company (DIN owner)
- 10445517 Canada IncLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Azithromycin J01FA10
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| AZITHROMYCIN (AZITHROMYCIN DIHYDRATE) | 250 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 4, 2024: NOC 32815Abbreviated New Drug Submission (ANDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named AZITHROMYCIN
- DIN 02330881 · Marketed
- DIN 02442434 · Marketed
- DIN 02274388 · Cancelled Post Market
- DIN 02274396 · Cancelled Post Market
- DIN 02330911 · Cancelled Post Market
- DIN 02342030 · Cancelled (Unreturned Annual)
- DIN 02342049 · Cancelled (Unreturned Annual)
- DIN 02343347 · Cancelled Pre Market
- DIN 02343355 · Cancelled Pre Market
- DIN 02418363 · Cancelled Pre Market
- DIN 02418371 · Cancelled Pre Market
- DIN 02477629 · Cancelled Pre Market
- DIN 02545977 · Approved